Noninvasive Biomarkers Can Improve Risk Assessment Of Patients With Suspected Prostate Cancer Prior To Biopsy, Study Indicates

HealthDay (5/19) reports researchers found “integration of data from multiple, noninvasive biomarkers can improve risk assessment of patients with a clinical suspicion of prostate cancer prior to an invasive biopsy.” The findings were published in Cancers...